Symbols / STE Stock $212.25 -1.00% STERIS plc

Healthcare • Medical Devices • United States • NYQ
STE (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Daniel A. Carestio
Exch · Country NYQ · United States
Market Cap 20.83B
Enterprise Value 22.46B
Income 708.52M
Sales 5.83B
FCF (ttm) 870.70M
Book/sh 72.93
Cash/sh 4.32
Employees 17,787
Insider 10d —
IPO Jun 01, 1992
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 33.47%
P/E 29.94
Forward P/E 19.16
PEG 1.64
P/S 3.57
P/B 2.91
P/C —
EV/EBITDA 14.26
EV/Sales 3.85
Quick Ratio 1.53
Current Ratio 2.48
Debt/Eq 28.65
LT Debt/Eq —
EPS (ttm) 7.09
EPS next Y 11.08
EPS Growth 12.10%
Revenue Growth 9.20%
EPS Gr Q/Q 11.20%
Rev Gr Q/Q —
Earnings (next) 2026-05-11
Earnings (prior) 2026-02-04
ROA 6.61%
ROE 10.47%
ROIC —
Gross Margin 44.32%
Oper. Margin 18.49%
Profit Margin 12.14%
Shs Outstand 98.08M
Shs Float 97.69M
Insider Own 0.30%
Instit Own 98.24%
Short Float 1.88%
Short Ratio 2.36
Short Interest 1.62M
52W High 269.44
vs 52W High -21.23%
52W Low 209.98
vs 52W Low 1.08%
Beta 0.95
Impl. Vol. 50.97%
Rel Volume 0.66
Avg Volume 820.68K
Volume 545.73K
Target (mean) $279.29
Tgt Median $291.00
Tgt Low $231.00
Tgt High $300.00
# Analysts 7
Recom Buy
Prev Close $214.40
Price $212.25
Change -1.00%
About

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$279.29
Mean price target
2. Current target
$212.25
Latest analyst target
3. DCF / Fair value
$159.80
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$212.25
Low
$231.00
High
$300.00
Mean
$279.29

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-08-08 main Morgan Stanley Overweight → Overweight $295
2025-07-22 main Keybanc Overweight → Overweight $288
2025-07-15 up Morgan Stanley Equal-Weight → Overweight $276
2025-05-29 init Jefferies — → Hold $263
2025-05-19 main Morgan Stanley Equal-Weight → Equal-Weight $260
2025-05-16 main JMP Securities Market Outperform → Market Outperform $280
2025-05-15 reit Stephens & Co. Overweight → Overweight $250
2025-05-12 main Morgan Stanley Equal-Weight → Equal-Weight $240
2025-04-10 reit JMP Securities Market Outperform → Market Outperform $265
2025-04-07 reit Needham Hold → Hold —
2025-02-06 reit JMP Securities Market Outperform → Market Outperform $265
2025-02-06 reit Stephens & Co. Overweight → Overweight $240
2025-02-03 main Piper Sandler Overweight → Overweight $265
2024-11-18 reit JMP Securities Market Outperform → Market Outperform $265
2024-11-08 reit Needham — → Hold —
2024-11-07 reit Stephens & Co. Overweight → Overweight $260
2024-10-24 up Piper Sandler Neutral → Overweight $260
2024-08-08 reit Needham — → Hold —
2024-08-07 reit JMP Securities Market Outperform → Market Outperform $265
2024-08-07 reit Stephens & Co. Overweight → Overweight $260
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-05 FELDMANN CYNTHIA L Director — 3,098 $237.21 $734,877
2026-03-05 FELDMANN CYNTHIA L Director — 3,098 $152.32 $471,887
2026-01-02 MCGOWAN LINDSEY Officer — 798 $0.00 $0
2025-11-21 MADSEN JULIA Officer — 5,008 $262.00 $1,312,096
2025-11-21 MADSEN JULIA Officer — 5,008 $114.22 $642,139
2025-11-18 TAMARO RENATO Officer and Treasurer — 5,036 $257.43 $1,297,040
2025-11-18 TAMARO RENATO Officer and Treasurer — 3,536 $182.22 $644,330
2025-11-11 ZANGERLE JOHN ADAM General Counsel — 15,000 $265.14 $3,977,100
2025-11-11 ZANGERLE JOHN ADAM General Counsel — 15,000 $69.72 $1,045,800
2025-10-06 CARESTIO DANIEL A Chief Executive Officer — 159 $241.82 $38,449
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Revenue
5,459.52
+6.24%
5,138.70
+13.28%
4,536.27
+7.41%
4,223.40
Operating Revenue
5,459.52
+6.24%
5,138.70
+13.28%
4,536.27
+7.41%
4,223.40
Cost Of Revenue
3,056.75
+4.66%
2,920.54
+14.28%
2,555.54
+9.19%
2,340.40
Reconciled Cost Of Revenue
3,056.75
+4.66%
2,920.54
+14.28%
2,555.54
+9.19%
2,340.40
Gross Profit
2,402.76
+8.32%
2,218.16
+11.99%
1,980.73
+5.19%
1,883.01
Operating Expense
1,441.92
+6.34%
1,356.00
+14.03%
1,189.14
-15.37%
1,405.14
Research And Development
107.65
+3.83%
103.68
+5.28%
98.48
+13.63%
86.66
Selling General And Administration
1,334.28
+6.54%
1,252.32
+14.82%
1,090.66
-17.28%
1,318.48
Total Expenses
4,498.68
+5.19%
4,276.54
+14.20%
3,744.68
-0.02%
3,745.54
Operating Income
960.84
+11.45%
862.16
+8.92%
791.59
+65.65%
477.86
Total Operating Income As Reported
866.64
+3.65%
836.12
+5.69%
791.10
+65.57%
477.81
EBITDA
1,358.68
-3.80%
1,412.40
+5.09%
1,344.00
+33.15%
1,009.40
Normalized EBITDA
1,445.46
+0.49%
1,438.45
+6.99%
1,344.48
+33.19%
1,009.45
Reconciled Depreciation
476.21
-15.75%
565.24
+2.23%
552.90
-0.04%
553.10
EBIT
882.47
+4.17%
847.16
+7.09%
791.10
+73.38%
456.29
Total Unusual Items
-86.77
-233.17%
-26.05
-5270.10%
-0.48
-910.42%
-0.05
Total Unusual Items Excluding Goodwill
-86.77
-233.17%
-26.05
-5270.10%
-0.48
-910.42%
-0.05
Special Income Charges
-86.77
-233.17%
-26.05
-5270.10%
-0.48
-910.42%
-0.05
Other Special Charges
48.15
—
—
—
Impairment Of Capital Assets
—
—
490.56
0.00
Restructuring And Mergern Acquisition
46.05
+76.81%
26.05
+5270.10%
0.48
+910.42%
0.05
Net Income
614.64
+62.50%
378.24
+253.40%
107.03
-56.12%
243.89
Pretax Income
796.21
+13.29%
702.81
+3.31%
680.27
+85.46%
366.80
Net Non Operating Interest Income Expense
-77.86
+41.59%
-133.31
-20.28%
-110.83
-33.21%
-83.21
Interest Expense Non Operating
86.26
-40.24%
144.35
+30.24%
110.83
+23.85%
89.49
Net Interest Income
-77.86
+41.59%
-133.31
-20.28%
-110.83
-33.21%
-83.21
Interest Expense
86.26
-40.24%
144.35
+30.24%
110.83
+23.85%
89.49
Interest Income Non Operating
8.40
-23.92%
11.04
—
6.28
Interest Income
8.40
-23.92%
11.04
—
6.28
Other Income Expense
-86.77
-233.17%
-26.05
-5270.10%
-0.48
+98.26%
-27.85
Other Non Operating Income Expenses
—
—
—
-27.81
Gain On Sale Of Business
7.42
0.00
0.00
—
Tax Provision
184.65
+23.49%
149.53
+20.52%
124.07
+50.67%
82.34
Tax Rate For Calcs
0.00
+8.92%
0.00
+17.03%
0.00
-20.18%
0.00
Tax Effect Of Unusual Items
-20.13
-262.89%
-5.55
-6184.79%
-0.09
-706.56%
-0.01
Net Income Including Noncontrolling Interests
616.07
+62.09%
380.08
+259.20%
105.81
-56.43%
242.87
Net Income From Continuing Operation Net Minority Interest
610.12
+10.64%
551.44
-1.07%
557.41
+95.26%
285.48
Net Income From Continuing And Discontinued Operation
614.64
+62.50%
378.24
+253.40%
107.03
-56.12%
243.89
Net Income Continuous Operations
611.56
+10.53%
553.28
-0.52%
556.20
+95.53%
284.46
Net Income Discontinuous Operations
4.52
+102.61%
-173.20
+61.54%
-450.38
-982.94%
-41.59
Minority Interests
-1.43
+22.12%
-1.84
-251.19%
1.22
+19.55%
1.02
Normalized Income
676.77
+18.33%
571.94
+2.53%
557.81
+95.37%
285.51
Net Income Common Stockholders
614.64
+62.50%
378.24
+253.40%
107.03
-56.12%
243.89
Diluted EPS
6.20
+62.73%
3.81
+256.07%
1.07
-56.85%
2.48
Basic EPS
6.24
+62.92%
3.83
+257.94%
1.07
-57.20%
2.50
Basic Average Shares
98.58
-0.21%
98.79
-0.92%
99.71
+2.23%
97.53
Diluted Average Shares
99.07
-0.29%
99.36
-0.88%
100.25
+1.95%
98.33
Diluted NI Availto Com Stockholders
614.64
+62.50%
378.24
+253.40%
107.03
-56.12%
243.89
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Assets
10,146.81
-8.29%
11,063.70
+2.23%
10,821.84
-5.27%
11,423.59
Current Assets
2,000.77
-30.27%
2,869.12
+42.64%
2,011.44
+7.05%
1,879.00
Cash Cash Equivalents And Short Term Investments
171.70
-17.06%
207.02
-0.64%
208.36
-40.18%
348.32
Cash And Cash Equivalents
171.70
-17.06%
207.02
-0.64%
208.36
-40.18%
348.32
Receivables
1,043.96
+3.54%
1,008.32
+16.57%
864.99
+8.25%
799.04
Accounts Receivable
1,043.96
+3.54%
1,008.32
+16.57%
864.99
+8.25%
799.04
Gross Accounts Receivable
1,068.32
+3.59%
1,031.30
+16.63%
884.27
+7.39%
823.41
Allowance For Doubtful Accounts Receivable
-24.35
-5.96%
-22.98
-19.19%
-19.28
+20.87%
-24.37
Inventory
581.33
-13.82%
674.53
+11.60%
604.41
+5.11%
575.00
Raw Materials
213.09
-13.36%
245.94
+11.57%
220.43
+13.02%
195.03
Work In Process
83.08
-15.49%
98.30
+4.61%
93.97
+23.61%
76.02
Finished Goods
334.93
-10.49%
374.18
+14.92%
325.61
-2.77%
334.88
Prepaid Assets
—
—
179.28
+14.45%
156.64
Assets Held For Sale Current
0.00
-100.00%
804.90
+410.79%
157.58
—
Other Current Assets
203.77
+16.88%
174.35
-1.00%
176.11
+12.43%
156.64
Total Non Current Assets
8,146.05
-0.59%
8,194.57
-6.99%
8,810.40
-7.69%
9,544.60
Net PPE
2,112.93
+9.00%
1,938.38
+7.73%
1,799.33
+3.35%
1,741.06
Gross PPE
3,844.05
+9.44%
3,512.33
+9.30%
3,213.43
+6.86%
3,007.27
Accumulated Depreciation
-1,731.11
-9.99%
-1,573.95
-11.30%
-1,414.10
-11.68%
-1,266.21
Properties
0.00
0.00
0.00
0.00
Land And Improvements
106.14
+17.75%
90.13
+15.92%
77.76
-7.45%
84.02
Buildings And Improvements
832.12
+14.86%
724.49
+10.09%
658.11
+0.50%
654.85
Machinery Furniture Equipment
1,205.41
+12.12%
1,075.08
+11.99%
959.95
+6.23%
903.65
Construction In Progress
512.14
+2.41%
500.11
+5.91%
472.21
+32.64%
356.01
Other Properties
1,188.24
+5.85%
1,122.51
+7.38%
1,045.41
+3.63%
1,008.74
Goodwill And Other Intangible Assets
5,950.07
-3.88%
6,189.99
+3.93%
5,955.92
-22.98%
7,732.88
Goodwill
4,095.68
+0.61%
4,070.71
+4.94%
3,879.22
-11.92%
4,404.34
Other Intangible Assets
1,854.39
-12.50%
2,119.28
+2.05%
2,076.70
-37.61%
3,328.54
Other Non Current Assets
83.05
+25.45%
66.20
-93.73%
1,055.15
+1393.26%
70.66
Total Liabilities Net Minority Interest
3,531.05
-25.64%
4,748.35
+0.29%
4,734.67
-2.96%
4,878.96
Current Liabilities
1,022.17
+9.78%
931.13
+8.04%
861.84
-6.55%
922.22
Payables And Accrued Expenses
358.45
+10.25%
325.14
-8.25%
354.36
+14.89%
308.43
Payables
302.23
+13.89%
265.36
-12.89%
304.64
+20.60%
252.61
Accounts Payable
280.77
+11.54%
251.72
-4.71%
264.17
+17.02%
225.74
Current Accrued Expenses
56.23
-5.93%
59.77
+20.23%
49.72
-10.94%
55.82
Employee Benefits
9.47
+2.85%
9.21
-8.83%
10.10
-3.52%
10.47
Pensionand Other Post Retirement Benefit Plans Current
192.68
+16.89%
164.83
+39.14%
118.46
-35.52%
183.72
Total Tax Payable
21.46
+57.30%
13.64
-66.30%
40.48
+50.62%
26.87
Income Tax Payable
21.46
+57.30%
13.64
-66.30%
40.48
+50.62%
26.87
Current Debt And Capital Lease Obligation
159.20
+35.86%
117.18
+30.10%
90.06
-49.78%
179.35
Current Debt
125.00
+45.45%
85.94
+43.23%
60.00
-58.01%
142.88
Other Current Borrowings
125.00
+45.45%
85.94
+43.23%
60.00
-58.01%
142.88
Current Capital Lease Obligation
34.20
+9.48%
31.24
+3.90%
30.07
-17.57%
36.47
Current Deferred Liabilities
57.50
-18.39%
70.46
-17.81%
85.73
-22.62%
110.79
Current Deferred Revenue
57.50
-18.39%
70.46
-17.81%
85.73
-22.62%
110.79
Other Current Liabilities
238.72
-0.41%
239.71
+19.04%
201.36
+55.19%
129.75
Total Non Current Liabilities Net Minority Interest
2,508.88
-34.27%
3,817.22
-1.44%
3,872.82
-2.12%
3,956.74
Liabilities Heldfor Sale Non Current
—
0.00
-100.00%
20.94
—
Long Term Debt And Capital Lease Obligation
2,043.34
-37.44%
3,265.99
+3.41%
3,158.21
+1.86%
3,100.54
Long Term Debt
1,918.70
-38.51%
3,120.16
+3.36%
3,018.66
+2.48%
2,945.48
Long Term Capital Lease Obligation
124.64
-14.53%
145.83
+4.49%
139.56
-10.00%
155.06
Long Term Provisions
37.83
+8.72%
34.79
+0.10%
34.76
+10.08%
31.57
Non Current Pension And Other Postretirement Benefit Plans
8.14
+3.23%
7.89
-11.85%
8.95
-1.77%
9.11
Tradeand Other Payables Non Current
1.88
-71.11%
6.51
-35.45%
10.08
-17.53%
12.22
Non Current Deferred Liabilities
403.65
-15.85%
479.69
-22.32%
617.54
-20.89%
780.62
Non Current Deferred Taxes Liabilities
403.65
-15.85%
479.69
-22.32%
617.54
-20.89%
780.62
Other Non Current Liabilities
12.71
-39.57%
21.04
-0.75%
21.20
-0.54%
21.31
Stockholders Equity
6,603.40
+4.78%
6,302.16
+3.70%
6,077.20
-6.97%
6,532.36
Common Stock Equity
6,603.40
+4.78%
6,302.16
+3.70%
6,077.20
-6.97%
6,532.36
Capital Stock
4,420.41
-2.70%
4,543.18
+1.27%
4,486.38
-5.41%
4,742.92
Common Stock
4,420.41
-2.70%
4,543.18
+1.27%
4,486.38
-5.41%
4,742.92
Share Issued
98.30
-0.59%
98.88
+0.26%
98.63
-1.44%
100.07
Ordinary Shares Number
98.30
-0.59%
98.88
+0.26%
98.63
-1.44%
100.07
Retained Earnings
2,475.33
+18.57%
2,087.64
+9.21%
1,911.53
-4.39%
1,999.24
Gains Losses Not Affecting Retained Earnings
-292.34
+11.05%
-328.66
-2.48%
-320.71
-52.86%
-209.81
Minority Interest
12.35
-6.30%
13.18
+32.16%
9.97
-18.79%
12.28
Other Equity Adjustments
-292.34
+11.05%
-328.66
-2.48%
-320.71
-52.86%
-209.81
Total Equity Gross Minority Interest
6,615.76
+4.76%
6,315.35
+3.75%
6,087.17
-6.99%
6,544.64
Total Capitalization
8,522.11
-9.55%
9,422.33
+3.59%
9,095.85
-4.03%
9,477.84
Working Capital
978.59
-49.50%
1,938.00
+68.58%
1,149.60
+20.15%
956.77
Invested Capital
8,647.11
-9.06%
9,508.26
+3.85%
9,155.85
-4.83%
9,620.71
Total Debt
2,202.54
-34.90%
3,383.17
+4.15%
3,248.28
-0.96%
3,279.88
Net Debt
1,872.00
-37.58%
2,999.08
+4.49%
2,870.30
+4.75%
2,740.04
Capital Lease Obligations
158.84
-10.29%
177.07
+4.39%
169.62
-11.44%
191.53
Net Tangible Assets
653.34
+482.45%
112.17
-7.51%
121.28
+110.10%
-1,200.52
Tangible Book Value
653.34
+482.45%
112.17
-7.51%
121.28
+110.10%
-1,200.52
Current Provisions
15.61
+13.04%
13.81
+16.39%
11.87
+16.63%
10.18
Interest Payable
7.81
-29.66%
11.11
+20.19%
9.24
-7.70%
10.01
Inventories Adjustments Allowances
-49.77
-13.40%
-43.89
-23.29%
-35.60
-15.08%
-30.94
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Cash Flow
1,148.09
+17.96%
973.27
+28.58%
756.95
+10.53%
684.81
Cash Flow From Continuing Operating Activities
1,148.09
+17.96%
973.27
+28.58%
756.95
+10.53%
684.81
Net Income From Continuing Operations
616.07
+62.09%
380.08
+259.20%
105.81
-56.43%
242.87
Depreciation Amortization Depletion
476.21
-15.75%
565.24
+2.23%
552.90
-0.04%
553.10
Other Non Cash Items
-3.75
-101.68%
223.58
+1379.88%
-17.47
-123.99%
72.83
Stock Based Compensation
57.40
+1.52%
56.53
+45.14%
38.95
-32.45%
57.66
Asset Impairment Charge
0.00
0.00
-100.00%
490.56
0.00
Deferred Tax
-76.55
+41.75%
-131.41
+29.32%
-185.91
-74.37%
-106.62
Deferred Income Tax
-76.55
+41.75%
-131.41
+29.32%
-185.91
-74.37%
-106.62
Operating Gains Losses
12.18
-51.91%
25.32
+14.45%
22.13
+55.35%
14.24
Gain Loss On Investment Securities
—
-0.55
—
—
Gain Loss On Sale Of PPE
5.74
-77.06%
25.00
+12.63%
22.19
+46.81%
15.12
Change In Working Capital
66.51
+145.53%
-146.08
+41.57%
-250.02
-67.49%
-149.28
Change In Receivables
-28.82
+77.50%
-128.07
+3.93%
-133.30
-156.51%
-51.97
Changes In Account Receivables
-28.82
+77.50%
-128.07
+3.93%
-133.30
-156.51%
-51.97
Change In Inventory
73.07
+295.12%
-37.45
+69.78%
-123.92
-20.40%
-102.92
Change In Payables And Accrued Expense
72.53
+245.49%
20.99
-32.90%
31.29
+2170.68%
-1.51
Change In Accrued Expense
38.94
-2.54%
39.95
+281.17%
-22.05
-34.49%
-16.40
Change In Payable
33.59
+277.14%
-18.96
-135.55%
53.34
+258.31%
14.89
Change In Account Payable
33.59
+277.14%
-18.96
-135.55%
53.34
+258.31%
14.89
Change In Other Current Assets
-50.27
-3139.18%
-1.55
+93.56%
-24.09
-438.00%
7.13
Investing Cash Flow
388.77
+143.81%
-887.36
-131.49%
-383.33
+42.49%
-666.56
Cash Flow From Continuing Investing Activities
388.77
+143.81%
-887.36
-131.49%
-383.33
+42.49%
-666.56
Net PPE Purchase And Sale
-360.90
-2.25%
-352.94
-1.60%
-347.38
-21.54%
-285.82
Purchase Of PPE
-370.09
-2.71%
-360.33
+0.45%
-361.97
-25.87%
-287.56
Sale Of PPE
9.20
+24.58%
7.38
-49.40%
14.59
+737.85%
1.74
Capital Expenditure
-370.09
-2.71%
-360.33
+0.45%
-361.97
-25.87%
-287.56
Net Investment Purchase And Sale
-10.75
-551.30%
2.38
0.00
0.00
Purchase Of Investment
-10.75
-616.67%
-1.50
0.00
0.00
Sale Of Investment
0.00
-100.00%
3.88
0.00
0.00
Net Business Purchase And Sale
760.42
+241.66%
-536.80
-1393.26%
-35.95
+90.56%
-380.74
Purchase Of Business
-54.14
+90.09%
-546.26
-1183.13%
-42.57
+92.27%
-550.45
Gain Loss On Sale Of Business
6.44
+1870.64%
0.33
+588.06%
-0.07
+92.33%
-0.87
Financing Cash Flow
-1,572.36
-1745.80%
-85.19
+82.92%
-498.72
-530.56%
115.83
Cash Flow From Continuing Financing Activities
-1,572.36
-1745.80%
-85.19
+82.92%
-498.72
-530.56%
115.83
Net Issuance Payments Of Debt
-1,164.43
-1058.49%
121.49
+2053.78%
-6.22
-101.67%
372.18
Issuance Of Debt
—
181.49
-24.90%
241.66
-87.92%
2,000.00
Repayment Of Debt
-1,164.43
-1840.72%
-60.00
+75.79%
-247.88
+82.76%
-1,437.64
Long Term Debt Issuance
—
181.49
-24.90%
241.66
-87.92%
2,000.00
Long Term Debt Payments
-1,164.43
-1840.72%
-60.00
+75.79%
-247.88
+82.76%
-1,437.64
Net Long Term Debt Issuance
-1,164.43
-1058.49%
121.49
+2053.78%
-6.22
-101.11%
562.36
Short Term Debt Payments
—
—
—
-190.17
Net Short Term Debt Issuance
—
181.49
-24.90%
241.66
+227.07%
-190.17
Net Common Stock Issuance
-211.32
-1696.18%
-11.77
+96.19%
-308.56
-453.21%
-55.78
Common Stock Payments
-211.32
-1696.18%
-11.77
+96.19%
-308.56
-453.21%
-55.78
Common Stock Dividend Paid
-219.88
-9.63%
-200.57
-9.30%
-183.50
-12.46%
-163.17
Cash Dividends Paid
-219.88
-9.63%
-200.57
-9.30%
-183.50
-12.46%
-163.17
Repurchase Of Capital Stock
-211.32
-1696.18%
-11.77
+96.19%
-308.56
-453.21%
-55.78
Proceeds From Stock Option Exercised
25.47
+143.21%
10.47
+472.87%
1.83
-81.85%
10.07
Net Other Financing Charges
-2.21
+54.09%
-4.81
-112.32%
-2.27
+95.23%
-47.48
Changes In Cash
-35.50
-4983.63%
0.73
+100.58%
-125.10
-193.30%
134.08
Effect Of Exchange Rate Changes
0.18
+108.96%
-2.06
+86.11%
-14.86
-136.17%
-6.29
Beginning Cash Position
207.02
-0.64%
208.36
-40.18%
348.32
+57.95%
220.53
End Cash Position
171.70
-17.06%
207.02
-0.64%
208.36
-40.18%
348.32
Free Cash Flow
778.00
+26.93%
612.95
+55.19%
394.98
-0.57%
397.25
Interest Paid Supplemental Data
89.40
-37.12%
142.17
+31.07%
108.47
+28.07%
84.70
Income Tax Paid Supplemental Data
273.61
+0.86%
271.27
+6.52%
254.66
+84.03%
138.38
Sale Of Business
814.56
+8512.37%
9.46
+42.78%
6.62
-96.10%
169.71
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category